Targeting the trehalose utilization pathways of Mycobacterium tuberculosis

Area of Science:

• Microbiology
• Drug Discovery
• Biochemistry

Background:

• Tuberculosis (TB) remains a global epidemic, exacerbated by multidrug-resistant strains (MDR-TB).
• Mycobacterium tuberculosis (Mtb) possesses a unique cell wall barrier and can enter dormant states, complicating treatment.
• Trehalose is a critical metabolite in Mtb, vital for cell wall integrity, nutrient storage, and stress resistance.

Purpose of the Study:

• To review current drug discovery strategies targeting enzymes within the trehalose utilization pathways (TUPs) of Mtb.
• To evaluate the potential of TUP enzymes as novel drug targets for combating TB, including MDR-TB.

Main Methods:

• Literature review of research on Mtb metabolism, cell wall structure, and trehalose biochemistry.
• Analysis of existing and potential drug discovery efforts focused on TUP enzymes.
• Assessment of the feasibility and challenges of targeting TUPs for anti-TB drug development.

Main Results:

• Trehalose plays multifaceted roles in Mtb survival and pathogenesis.
• Enzymes in the TUPs are essential for Mtb's unique metabolic and structural requirements.
• Several TUP enzymes represent viable targets for novel anti-TB drug development.

Conclusions:

• Targeting trehalose utilization pathways presents a rational approach for developing new anti-TB drugs.
• Inhibition of TUPs could disrupt Mtb's cell wall synthesis, energy metabolism, and stress survival mechanisms.
• Further research into TUP enzyme inhibitors is warranted to address the urgent need for effective TB treatments.